1. In Vivo
  2. >>Innovation

Parkinson’s Disease: Ripe For A Rethink

Developments In A Burgeoning Market

 
• By Jo Shorthouse

Despite decades of R&D, there are no disease modifying therapies on the market for Parkinson’s disease, and few efficacious products for non-motor symptoms. Clinical setbacks have been rife but breakthroughs in diagnostics and a better understanding of disease pathology brings hope for the future. In Vivo speaks to some of those responsible for bringing innovation to the field. 

Brain jigsaw
Cases of Parkinson's Disease expected to increase by 30.8% worldwide between 2018 and 2027

Parkinson’s disease affects over 10 million people, a huge market that has no disease modifying treatments. Our aging population will catalyze this unmet need, and Datamonitor Healthcare forecasts the number of prevalent cases of PD to increase by 30.8% worldwide between 2018 and 2027.

Key Takeaways

  • By 2031, the Parkinson’s disease market in the US, Japan and five major EU markets is forecast to reach just over $6bn.

By 2031, the market in the US, Japan and the five major EU markets is forecast to reach just over...

More from Innovation

More from In Vivo

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By Jo Shorthouse

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

 
• By Anabel Costa-Ferreira

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

Behind The Buyout: Dispatches From The Dealmaking Table

 
• By Jo Shorthouse

In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.